|

Sacituzumab Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Sacituzumab Govitecan

Pipeline

Phase 1/2: 1

Top Sponsors

  • Icahn School of Medicine at Mount Sinai1

Indications

  • Malignant Neoplasm of Uterus1
  • Ovarian Cancer1
  • Cancer1

New York, New York1 trial

Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer

Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.